dipyridamole has been researched along with losartan potassium in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (75.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Belch, JJ; Henderson, IS; Stewart, WK; Taylor, JE | 1 |
| Arrobas, M; Caravaca, F; Cid, MC; Cubero, J; López-Minguez, JR; Miranda, MP; Pizarro, JL; Sanchez-Casado, E | 1 |
| Delabar, U; Eckardt, KU; Freudenthaler, S; Gleiter, CH; Gundert-Remy, U; Mühlbauer, B; Osswald, H | 1 |
| Brause, M; Delabar, U; Eckardt, KU; Gleiter, CH; Zebski, H | 1 |
| Becker, T; Gleiter, CH; Wenzel, J | 1 |
| Hosoya, T; Kuriyama, S; Tomonari, H | 1 |
| Minnerup, J; Schäbitz, WR | 1 |
1 review(s) available for dipyridamole and losartan potassium
| Article | Year |
|---|---|
Multifunctional actions of approved and candidate stroke drugs.
Topics: Albumins; Animals; Antihypertensive Agents; Aspirin; Brain Ischemia; Clopidogrel; Cytidine Diphosphate Choline; Dipyridamole; Erythropoietin; Granulocyte Colony-Stimulating Factor; Humans; Hypolipidemic Agents; Neuroprotective Agents; Platelet Aggregation Inhibitors; Stroke; Ticlopidine | 2009 |
4 trial(s) available for dipyridamole and losartan potassium
| Article | Year |
|---|---|
Erythropoietin and spontaneous platelet aggregation in haemodialysis patients.
Topics: Anemia; Aspirin; Blood Coagulation; Dipyridamole; Erythropoietin; Humans; In Vitro Techniques; Kidney Failure, Chronic; Platelet Aggregation; Renal Dialysis | 1991 |
Haemodynamic changes induced by the correction of anaemia by erythropoietin: role of antiplatelet therapy.
Topics: Adult; Aged; Anemia; Aspirin; Dipyridamole; Erythropoietin; Female; Hemodynamics; Humans; Male; Middle Aged; Oxazoles; Platelet Aggregation Inhibitors; Prospective Studies; Recombinant Proteins; Renal Dialysis; Ticlopidine; Time Factors; Uremia | 1995 |
Erythropoietin production in healthy volunteers subjected to controlled haemorrhage: evidence against a major role for adenosine.
Topics: Adenosine; Adult; Area Under Curve; Cardiovascular Agents; Creatinine; Dipyridamole; Erythropoietin; Hematocrit; Hemoglobins; Hemorrhage; Humans; Male; Phlebotomy; Phosphodiesterase Inhibitors; Single-Blind Method; Theophylline | 1996 |
Erythropoietin production in healthy volunteers subjected to controlled hypobaric hypoxia: further evidence against a role for adenosine.
Topics: Adenosine; Adult; Area Under Curve; Atmosphere Exposure Chambers; Dipyridamole; Erythropoietin; Humans; Hypoxia; Kidney; Male; Placebos; Reference Values; Single-Blind Method; Theophylline | 1997 |
3 other study(ies) available for dipyridamole and losartan potassium
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Evidence against a major role of adenosine in oxygen-dependent regulation of erythropoietin in rats.
Topics: Adenine; Adenosine; Adenosine Diphosphate; Animals; Antihypertensive Agents; Carbon Monoxide; Dipyridamole; Diuretics; Drug Synergism; Enzyme Inhibitors; Erythropoietin; Gene Expression; Hypoxia; Kidney; Male; Oxygen; Phenethylamines; Phosphodiesterase Inhibitors; Piperazines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; RNA, Messenger; Theophylline; Vasodilator Agents; Xanthines | 1997 |
Antiplatelet therapy decreases the incidence of erythropoietin-induced hypertension in predialysis patients.
Topics: Adult; Aged; Anemia; Dilazep; Dipyridamole; Erythropoietin; Female; Hematocrit; Humans; Hypertension; Kidney Diseases; Male; Middle Aged; Platelet Aggregation Inhibitors; Recombinant Proteins; Renal Dialysis; Risk Factors | 1999 |